본문 바로가기
KERD
논문KCI 등재

The serine threonine kinase RIP3: lost and found

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류화학

초록

Receptor-interacting protein kinase-3 (RIP3, or RIPK3) is an essential protein in the “programmed”, or “regulated” necrosis cell death pathway that is activated in response to death receptor ligands and other types of cellular stress. Programmed necrotic cell death is distinguished from its apoptotic counterpart in that it is not characterized by the activation of caspases; unlike apoptosis, programmed necrosis results in plasma membrane rupture, thus spilling the contents of the cell and triggering the activation of the immune system and inflammation. Here we discuss findings, including our own recent data, which show that RIP3 protein expression is absent in many cancer cell lines. The recent data suggests that the lack of RIP3 expression in a majority of these deficient cell lines is due to methylation-dependent silencing, which limits the responses of these cells to pro-necrotic stimuli. Importantly, RIP3 expression may be restored in many cancer cells through the use of hypomethylating agents, such as decitabine. The potential implications of loss of RIP3 expression in cancer are explored, along with possible consequences for chemotherapeutic response.

Abstract

Receptor-interacting protein kinase-3 (RIP3, or RIPK3) is an essential protein in the “programmed”, or “regulated” necrosis cell death pathway that is activated in response to death receptor ligands and other types of cellular stress. Programmed necrotic cell death is distinguished from its apoptotic counterpart in that it is not characterized by the activation of caspases; unlike apoptosis, programmed necrosis results in plasma membrane rupture, thus spilling the contents of the cell and triggering the activation of the immune system and inflammation. Here we discuss findings, including our own recent data, which show that RIP3 protein expression is absent in many cancer cell lines. The recent data suggests that the lack of RIP3 expression in a majority of these deficient cell lines is due to methylation-dependent silencing, which limits the responses of these cells to pro-necrotic stimuli. Importantly, RIP3 expression may be restored in many cancer cells through the use of hypomethylating agents, such as decitabine. The potential implications of loss of RIP3 expression in cancer are explored, along with possible consequences for chemotherapeutic response.

참고문헌 (73)

  1. Vandenabeele P, "Molecular mechanisms of necroptosis: an ordered cellular explosion", Nat Rev Mol Cell Biol, 11, pp.700~714 (2010)
  2. Vanlangenakker N, "Many stimuli pull the necrotic trigger, an overview", Cell Death Differ, 19, pp.75~86 (2012)
  3. Morgan M, "Programmed cell death with a necrotic-like phenotype", Biomol Concepts, 4, pp.259~275 (2013)
  4. Kroemer G, "Classification of cell death: recommendations of the Nomenclature Committee on Cell Death", Cell Death Differ, 12(2), pp.1463~1467 (2005)
  5. Fiers W, "More than one way to die: apoptosis, necrosis and reactive oxygen damage", Oncogene, 18, pp.7719~7730 (1999)
  6. Moriwaki K, "RIP3 : a molecular switch for necrosis and inflammation", Genes Dev, 27, pp.1640~1649 (2013)
  7. Linkermann A, "Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury", Proc Nat Acad Sci U S A, 110, pp.12024~12029 (2013)
  8. Kaiser WJ, "Viral modulation of programmed necrosis", Curr Opin Virol, 3, pp.296~306 (2013)
  9. Ofengeim D, "Activation of Necroptosis in Multiple Sclerosis", Cell Rep, 10, pp.1836~1849 (2015)
  10. Lin Y, "Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation", J Biol Chem, 279, pp.10822~10828 (2004)
  11. Holler N, "Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule", Nat Immunol, 1, pp.489~495 (2000)
  12. Michael J. Morgan, "Reactive Oxygen Species in TNF alpha-Induced Signaling and Cell Death", Molecules and Cells, 30(1), pp.1~12 (2010), 한국분자세포생물학회
  13. Devin A, "The role of the deathdomain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases", EMBO Rep, 4, pp.623~627 (2003)
  14. Degterev A, "Identification of RIP1 kinase as a specific cellular target of necrostatins", Nat Chem Biol, 4, pp.313~321 (2008)
  15. Chan FK, "A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses", J Biol Chem, 278, pp.51613~51621 (2003)
  16. Degterev A, "Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury", Nat Chem Biol, 1, pp.112~119 (2005)
  17. Cho YS, "Phosphorylationdriven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation", Cell, 137, pp.1112~1123 (2009)
  18. He S, "Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha", Cell, 137, pp.1100~1111 (2009)
  19. Zhang DW, "RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis", Science, 325, pp.332~336 (2009)
  20. Sun X, "Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein(RIP)by RIP3", J Biol Chem, 277, pp.9505~9511 (2002)
  21. Li J, "The RIP1", RIP3Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis, 2012, pp.150, 339~350
  22. Rickard JA, "RIPK1regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis", Cell, 157, pp.1175~1188 (2014)
  23. Dillon CP, "RIPK1blocks early postnatal lethality mediated by caspase-8 and RIPK3", Cell, 157, pp.1189~1202 (2014)
  24. Orozco S, "RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis", Cell Death Differ, 21, pp.1511~1521 (2014)
  25. Dannappel M, "RIPK1maintains epithelial homeostasis by inhibiting apoptosis and necroptosis", Nature, 513, pp.90~94 (2014)
  26. Zhao J, "Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis", Proc Natl Acad Sci U S A, 109, pp.5322~5327 (2012)
  27. Sun L, "Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase", Cell, 148, pp.213~227 (2012)
  28. Wu JF, "Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis", Cell Res, 23, pp.994~1006 (2013)
  29. Murphy JM, "The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism", Immunity, 39, pp.443~453 (2013)
  30. Wang HY, "Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3", Mol Cell, 54, pp.133~146 (2014)
  31. Cai ZY, "Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis", Nat Cell Biol, 16, pp.55~56 (2014)
  32. Chen X, "Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death", Cell Res, 24, pp.105~121 (2014)
  33. Dondelinger Y, "MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates", Cell Rep, 7, pp.971~981 (2014)
  34. Hildebrand JM, "Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death", Proc Natl Acad Sci U S A, 111, pp.15072~15077 (2014)
  35. Cook WD, "RIPK1-and RIPK3-induced cell death mode is determined by target availability", Cell Death Differ, 21, pp.1600~1612 (2014)
  36. Bonnet MC, "The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation", Immunity, 35, pp.572~582 (2011)
  37. Ch'en IL, "Mechanisms of necroptosis in T cells", J Exp Med, 208, pp.633~641 (2011)
  38. Dillon CP, "Survival function of the FADD-CASPASE-8-cFLIP(L)complex", Cell Rep, 1, pp.401~407 (2012)
  39. Kaiser WJ, "RIP3 mediates the embryonic lethality of caspase-8-deficient mice", Nature, 471, pp.368~372 (2011)
  40. Lu JV, "Complementary roles of Fas-associated death domain(FADD)and receptor interacting protein kinase-3(RIPK3)in T-cell homeostasis and antiviral immunity", Proc Natl Acad Sci U S A, 108, pp.15312~15317 (2011)
  41. Moulin M, "IAPs limit activation of RIP kinases by TNF receptor 1 during development", EMBO J, 31, pp.1679~1691 (2012)
  42. Oberst A, "Catalytic activity of the caspase-8-FLIP(L)complex inhibits RIPK3-dependent necrosis", Nature, 471, pp.363~367 (2011)
  43. Zhang HB, "Functional complementation between FADD and RIP1 in embryos and lymphocytes", Nature, 471, pp.373~376 (2011)
  44. Vercammen D, "Inhibition of caspases increases the sensitivity of L929cells to necrosis mediated by tumor necrosis factor", J Exp Med, 187, pp.1477~1485 (1998)
  45. Lin Y, "Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis", Genes Dev, 13, pp.2514~2526 (1999)
  46. Feng S, "Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain", Cell Signal, 19, pp.2056~2067 (2007)
  47. O'Donnell MA, "Caspase 8 inhibits programmed necrosis by processing CYLD", Nat Cell Biol, 13, pp.1437~1442 (2011)
  48. Lu JV, "Complementary roles of Fas-associated death domain(FADD)and receptor interacting protein kinase-3(RIPK3)in T-cell homeostasis and antiviral immunity", Proc Nat Acad Sci U S A, 108, pp.15312~15317 (2011)
  49. Gunther C, "Caspase-8regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis", Nature, 477, pp.335~108 (2011)
  50. Welz PS, "FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation", Nature, 477, pp.330~102 (2011)
  51. Grooten J, "Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity", Cytokine, 5, pp.546~555 (1993)
  52. Laster SM, "Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis", J Immunol 141, 141, pp.2629~2634 (1988)
  53. Denecker G, "Death receptor-induced apoptotic and necrotic cell death:differential role of caspases and mitochondria", Cell Death Differ, 8, pp.829~840 (2001)
  54. Sakon S, "NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death", EMBO J, 22, pp.3898~3909 (2003)
  55. Yu PW, "Identification of RIP3, a RIP-like kinase that activates apoptosis and NF kappa B", Curr Biol, 9, pp.539~542 (1999)
  56. Sun XQ, "RIP3, a novel apoptosis-inducing kinase", J Biol Chem, 274, pp.16871~16875 (1999)
  57. Kasof GM, "The RIP-like kinase, RIP3, induces apoptosis and NF-kappa B nuclear translocation and localizes to mitochondria", FEBS Lett, 473, pp.285~291 (2000)
  58. Koo G-B, "Methylation-Dependent Loss of RIP3 Expression in Cancer Represses Programmed Necrosis in Response to Chemotherapeutics", Cell Res, 25, pp.707~725 (2015)
  59. Yang Y, "RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3(RIP3), downregulate RIP3-induced apoptosis", Biochem Biophys Res Commun, 332, pp.181~187 (2005)
  60. Newton K, "Kinase RIP3 is dispensable for normal NF-KBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4", Mol Cell Biol, 24, pp.1464~1469 (2004)
  61. Hanahan D, "Hallmarks of Cancer: The Next Generation", Cell, 144, pp.646~674 (2011)
  62. Nugues AL, "RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65", RelA cleavage, 2014, pp.5, e1384~
  63. Liu XY, "RIP1 Kinase Is an Oncogenic Driver in Melanoma", Cancer Res, 75, pp.1736~1748 (2015)
  64. Fukasawa M, "Microarray analysis of promoter methylation in lung cancers", J Hum Genet, 51, pp.368~374 (2006)
  65. Zong WX, "Alkylating DNA damage stimulates a regulated form of necrotic cell death", Genes Dev, 18, pp.1272~1282 (2004)
  66. David KK, "Parthanatos, a messenger of death", Front Biosci, 14, pp.1116~1128 (2009)
  67. Sosna J, "TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death", Cell Mol Life Sci, 71, pp.331~348 (2014)
  68. Tenev T, "The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs", Mol Cell, 43, pp.432~448 (2011)
  69. Feoktistova M, "cIAPs Block Ripoptosome Formation, a RIP1", Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms, 2011, pp.43, 449~463
  70. Biton S, "NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling", Cell, 145, pp.92~103 (2011)
  71. Li JX, "The B-Raf(V600E)inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury", Cell Death Dis, 5, pp.e1278~ (2014)
  72. Kim SK, "Upregulated RIP3Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis", J Invest Dermatol (2015)
  73. Motani K, "Caspase-1 Protein Induces Apoptosis-associated Speck-like Protein Containing a Caspase Recruitment Domain(ASC)mediated Necrosis Independently of Its Catalytic Activity", J Biol Chem, 286, pp.33963~33972 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (10건)